These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
520 related items for PubMed ID: 9264011
21. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Vychytil A, Födinger M, Wölfl G, Enzenberger B, Auinger M, Prischl F, Buxbaum M, Wiesholzer M, Mannhalter C, Hörl WH, Sunder-Plassmann G. Kidney Int; 1998 Jun; 53(6):1775-82. PubMed ID: 9607212 [Abstract] [Full Text] [Related]
22. A C677T mutation in the methylenetetrahydrofolate reductase gene modifies serum cysteine in dialysis patients. Kimura H, Gejyo F, Suzuki S, Takeda T, Miyazaki R, Yoshida H. Am J Kidney Dis; 2000 Nov; 36(5):925-33. PubMed ID: 11054348 [Abstract] [Full Text] [Related]
23. Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: impact on homocysteine and folic acid status and reference intervals. Ozarda Y, Sucu DK, Hizli B, Aslan D. Cell Biochem Funct; 2009 Dec; 27(8):568-77. PubMed ID: 19764044 [Abstract] [Full Text] [Related]
28. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Circulation; 1996 Nov 15; 94(10):2410-6. PubMed ID: 8921781 [Abstract] [Full Text] [Related]
29. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH. Atherosclerosis; 1996 Jun 15; 123(1-2):193-202. PubMed ID: 8782850 [Abstract] [Full Text] [Related]
30. Prevalence of methylenetetrahydrofolate gene (MTHFR) C677T polymorphism among chronic hemodialysis patients and its association with cardiovascular disease: a cross-sectional analysis. Ibrahim S, El Dessokiy O. Clin Exp Nephrol; 2009 Oct 15; 13(5):501-507. PubMed ID: 19466593 [Abstract] [Full Text] [Related]
31. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Girelli D, Friso S, Trabetti E, Olivieri O, Russo C, Pessotto R, Faccini G, Pignatti PF, Mazzucco A, Corrocher R. Blood; 1998 Jun 01; 91(11):4158-63. PubMed ID: 9596662 [Abstract] [Full Text] [Related]
32. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. Jacques PF, Kalmbach R, Bagley PJ, Russo GT, Rogers G, Wilson PW, Rosenberg IH, Selhub J. J Nutr; 2002 Feb 01; 132(2):283-8. PubMed ID: 11823591 [Abstract] [Full Text] [Related]
33. Association between the MTHFR C677T polymorphism, blood folate and vitamin B12 deficiency, and elevated serum total homocysteine in healthy individuals in Yunnan Province, China. Ni J, Zhang L, Zhou T, Xu WJ, Xue JL, Cao N, Wang X. J Chin Med Assoc; 2017 Mar 01; 80(3):147-153. PubMed ID: 28094233 [Abstract] [Full Text] [Related]
34. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: a study in 52 healthy subjects. Zittoun J, Tonetti C, Bories D, Pignon JM, Tulliez M. Metabolism; 1998 Nov 01; 47(11):1413-8. PubMed ID: 9826223 [Abstract] [Full Text] [Related]
35. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. Cardo E, Monrós E, Colomé C, Artuch R, Campistol J, Pineda M, Vilaseca MA. J Child Neurol; 2000 May 01; 15(5):295-8. PubMed ID: 10830195 [Abstract] [Full Text] [Related]
36. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Hauser AC, Hagen W, Rehak PH, Buchmayer H, Födinger M, Papagiannopoulos M, Bieglmayer C, Apsner R, Köller E, Ignatescu M, Hörl WH, Sunder-Plassmann G. Am J Kidney Dis; 2001 Apr 01; 37(4):758-65. PubMed ID: 11273876 [Abstract] [Full Text] [Related]
37. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay. Herrmann W, Obeid R, Schorr H, Zarzour W, Geisel J. Clin Chem Lab Med; 2003 Apr 01; 41(4):547-53. PubMed ID: 12747601 [Abstract] [Full Text] [Related]
38. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, Kruyssen DA. Atherosclerosis; 1997 Jul 11; 132(1):105-13. PubMed ID: 9247365 [Abstract] [Full Text] [Related]
39. Role of folic acid depletion on homocysteine serum level in children and adolescents with epilepsy and different MTHFR C677T genotypes. Coppola G, Ingrosso D, Operto FF, Signoriello G, Lattanzio F, Barone E, Matera S, Verrotti A. Seizure; 2012 Jun 11; 21(5):340-3. PubMed ID: 22425007 [Abstract] [Full Text] [Related]
40. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Chango A, Potier De Courcy G, Boisson F, Guilland JC, Barbé F, Perrin MO, Christidès JP, Rabhi K, Pfister M, Galan P, Hercberg S, Nicolas JP. Br J Nutr; 2000 Dec 11; 84(6):891-6. PubMed ID: 11177206 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]